Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by canadafanon Oct 29, 2023 4:34pm
435 Views
Post# 35706486

The week ahead

The week ahead

First what we know for sure.
This coming Friday, Onc will be having Q3 results, updates & general progress.
That event is not newsworthy. As it is a legal requirement only.
Simoly put, part if on- going process.

We also know, last week some decent results were confirmed for tge Pancreatice cancer arm. In addition to that the colorectal cancer arm, data was good enough to allow progress to the next stage.
both of these in coterapy within the Roche Goblet trial.

We also know, Onc was selected for a $5million grant to add another co- therapy arm to the pancreatic cancer opportunities.

We also know the " within 90 day update";of the special PanCan phase 3 trial details are now long over due.
Could be the $5 million grant changed the negotiations a bit. As a logical minimum, would 100% change any in place paperwork.

so?
This Friday?
unless there is a N.R. This week prior, they do need to address the delay...of the " within 90 day update".
A simple nod to its existence & " we are working in it";woukd be suffice.
Total non- denial , denial of the timeline & where things are would not be precived or received well.
I appreciate 100% the Q3 update is a forced date. The negotiations are not & do not need to match any outside dates.
HOWEVER, outside communications are very important to build sentiment & gain traction with the SP.

My commentary;
The last few weeks of data & news has been great. The future for onc is at a crossroads.
Multiple irons in the fire. 
Six/ six anakysts with buy ir string buy recommendations. Withn targets well above existing.
My gut feelings , this week will have some interesting surprises.
side story...
Last Sat, I met a random, very educated & on the ball investor.
we talked mostly about energy stocks.
i Did ask if she knew about biotech, specifically Onc?
She has been following for an extended period of time. 
Has not bought yet.
interesting, first comment from her on Onc " They will be getting bought out & soon".
again, totally random. Don't know this lady at all.
I do know she follows multiple investments & investment T.V. Shows.
Her comments in one context, meaningless.
however, a point of view I I found quite interesting.
have a great week all.
enjoy this great country we call home.

 

 


 

<< Previous
Bullboard Posts
Next >>